Targeting the gut-liver axis in cirrhosis: antibiotics and non-selective β-blockers
- PMID: 23881723
- DOI: 10.1007/s12325-013-0044-1
Targeting the gut-liver axis in cirrhosis: antibiotics and non-selective β-blockers
Abstract
The gut-liver axis in cirrhosis and portal hypertension is gaining increasing attention as a key pathophysiological mechanism responsible for progression of liver failure and development of complications such as spontaneous infections and hepatocellular carcinoma. Antibiotics and non-selective β-blockers (NSBB) intercept this axis and each drug has proven efficacy in clinical trials. A synergistic effect is a hitherto unproven possibility. There is an increasing body of evidence supporting improved outcome with expanded use of NSBB and antibiotic therapy beyond current indications. This review addresses the issue of pharmacological treatment of cirrhosis and portal hypertension with antibiotics and NSBB. We discuss their mechanism of action and suggest that combining the two treatment modalities could potentially reduce the risk of complications.
Similar articles
-
[Managing the complications of cirrhosis].Rev Prat. 2005 Sep 30;55(14):1555-63. Rev Prat. 2005. PMID: 16255297 French.
-
Could antioxidants be the "magic pill" for cirrhosis-related complications? A pathophysiological appraisal.Med Hypotheses. 2011 Sep;77(3):419-23. doi: 10.1016/j.mehy.2011.05.034. Epub 2011 Jun 23. Med Hypotheses. 2011. PMID: 21703771
-
Can non-selective beta-blockers prevent hepatocellular carcinoma in patients with cirrhosis?Med Hypotheses. 2013 Nov;81(5):871-4. doi: 10.1016/j.mehy.2013.08.026. Epub 2013 Sep 4. Med Hypotheses. 2013. PMID: 24060485
-
Current and future pharmacological therapies for managing cirrhosis and its complications.World J Gastroenterol. 2019 Feb 28;25(8):888-908. doi: 10.3748/wjg.v25.i8.888. World J Gastroenterol. 2019. PMID: 30833797 Free PMC article. Review.
-
Outpatient management of cirrhosis: a narrative review.South Med J. 2006 Jun;99(6):600-6. doi: 10.1097/01.smj.0000220889.36995.54. South Med J. 2006. PMID: 16800415 Review.
Cited by
-
Precipitants of Acute-on-Chronic Liver Failure: An Opportunity for Preventative Measures to Improve Outcomes.Liver Transpl. 2020 Feb;26(2):283-293. doi: 10.1002/lt.25678. Epub 2020 Jan 6. Liver Transpl. 2020. PMID: 31714011 Free PMC article. Review.
-
Prebiotics: A Novel Approach to Treat Hepatocellular Carcinoma.Can J Gastroenterol Hepatol. 2017;2017:6238106. doi: 10.1155/2017/6238106. Epub 2017 May 10. Can J Gastroenterol Hepatol. 2017. PMID: 28573132 Free PMC article. Review.
-
The effect of propranolol on gastrointestinal motility and permeability in patients with cirrhosis and significant portal hypertension.BMC Gastroenterol. 2024 Nov 21;24(1):420. doi: 10.1186/s12876-024-03483-6. BMC Gastroenterol. 2024. PMID: 39574005 Free PMC article.
-
Non-Selective Beta-Blockers and Risk of Sepsis in Patients with Cirrhosis and Ascites: Results from a Large Observational Study.Clin Epidemiol. 2023 Jun 21;15:775-783. doi: 10.2147/CLEP.S400399. eCollection 2023. Clin Epidemiol. 2023. PMID: 37366419 Free PMC article.
-
Gut Microbiota and Hepatocellular Carcinoma.Gastrointest Tumors. 2015 May;2(1):33-40. doi: 10.1159/000380895. Epub 2015 Apr 22. Gastrointest Tumors. 2015. PMID: 26673641 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
